Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide plus oral sulfate solution for bowel preparation in chronic constipation patients undergoing colonoscopy
ChiCTR2500096394Phase 4Not yet recruiting
- Sponsor
- Beijing Shijitan Hospital
- Start
- Jan 2025
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of linaclotide and sodium sulfate + potassium sulfate + magnesium sulfate in chronic constipation (3 arms), sponsored by Beijing Shijitan Hospital. Primary endpoint: Quality of bowel preparation. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
linaclotidesodium sulfate + potassium sulfate + magnesium sulfate
03
Conditions
chronic constipation
Beyond the preview
Go deeper on ChiCTR2500096394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096394.